BSYI — BioSyntech Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for BioSyntech, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2005 March 31st | 2006 March 31st | 2007 March 31st | C2008 March 31st | 2009 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.14 | -6.86 | -8.11 | -9.27 | -12.9 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.827 | 1.18 | 0.524 | 0.431 | 3.14 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.058 | -0.871 | -0.34 | 0.072 | -0.129 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.88 | -6.18 | -7.53 | -8.38 | -9.57 |
| Capital Expenditures | -0.317 | -0.259 | -0.349 | -0.12 | -0.233 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1 | -6.25 | -1.64 | 7.89 | 0 |
| Change in Net Investments | |||||
| Cash from Investing Activities | 0.685 | -6.51 | -1.99 | 7.77 | -0.233 |
| Financing Cash Flow Items | -0.256 | -0.662 | -1.07 | -0.017 | -1.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.29 | 16.4 | 8.91 | -0.585 | 10.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.919 | 3.74 | -0.599 | -1.2 | 0.967 |